Tatsunori Takahashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tatsunori Takahashi has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Yuhei Kobayashi
NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, USA; Weill Cornell Medical College, New York, New York, USA
5 shared publications - Edward T. Ha
Section of Interventional Cardiology, MedStar Washington Hospital Center Washington District of Columbia USA
4 shared publications Frederik M. Zimmermann
Catharina Hospital, Eindhoven, the Netherlands (F.M.Z., N.H.J.P.).
4 shared publicationsWilliam F. Fearon
4 shared publicationsAlan C. Yeung
Cardiovascular Medicine and Stanford Cardiovascular Institute, Stanford University, CA (H.O., K.T., A.C.Y., W.F.F.).
3 shared publicationsAzeem Latib
Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
3 shared publications
Latest Publications
- 1 September 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (9)
Stability of Compounded Intracoronary Acetylcholine and Implications for Beyond-Use Dating
- 1 September 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (9)
Stability of Compounded Intracoronary Acetylcholine and Implications for Beyond-Use Dating
- 12 January 2026
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (1) , 28-30
Pursuit of State-of-the-Art PCI With Imaging and Physiology
- 12 January 2026
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 19 (1) , 28-30
Pursuit of State-of-the-Art PCI With Imaging and Physiology
- 15 July 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (13) , 1631-1642
Outcomes of Lesions With Discordance Between FFR and Nonhyperemic Pressure Ratios
- 15 July 2025
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 18 (13) , 1631-1642
Outcomes of Lesions With Discordance Between FFR and Nonhyperemic Pressure Ratios
- 13 February 2025
- Published by Elsevier in The American Journal of Cardiology
- Vol. 243, 40-44
Extensive Pericardial Metastasis of Angiosarcoma: Diagnostic Challenge in a Young Case With Effusive Constrictive Pericarditis
- 13 February 2025
- Published by Elsevier in The American Journal of Cardiology
- Vol. 243, 40-44
Extensive Pericardial Metastasis of Angiosarcoma: Diagnostic Challenge in a Young Case With Effusive Constrictive Pericarditis
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (11) , e014300
Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy
BACKGROUND: The clinical impact of a chronic total occlusion (CTO) in patients with 3-vessel coronary artery disease undergoing fractional flow reserve–guided percutaneous coronary intervention (PCI) with current-generation drug-eluting stents or coronary artery bypass grafting (CABG) is unclear. METHODS: The FAME 3 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 3) compared fractional flow reserve–guided PCI with CABG in patients with 3-vessel coronary artery disease. The primary end point was major adverse cardiac and cerebrovascular events, a composite of death, myocardial infarction, stroke, or repeat revascularization at 1 year. In this substudy, the 3-year outcomes were analyzed in patients with or without a CTO. RESULTS: Of the patients randomized to PCI or CABG in the FAME 3 trial, 305 (21%) had a CTO. In the PCI arm, revascularization of the CTO was attempted in 61% with a procedural success rate of 88%. The incidence of major adverse cardiac and cerebrovascular events at 3 years was not significantly different between those with or without a CTO in both the PCI (15.2% versus 20.1%; adjusted hazard ratio, 0.62 [95% CI, 0.38–1.03]; P =0.07) and the CABG (13.0% versus 12.9%; adjusted hazard ratio, 0.96 [95% CI, 0.55–1.66]; P =0.88) arms. In those without a CTO, PCI was associated with a significantly higher risk of major adverse cardiac and cerebrovascular events compared with CABG (adjusted hazard ratio, 1.61 [95% CI, 1.20–2.17]; P P =0.56; P interaction =0.31). CONCLUSIONS: The presence of a CTO did not significantly impact the treatment effect of PCI versus CABG at 3 years in patients with 3-vessel coronary artery disease. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02100722.
- 1 November 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (11) , e014300
Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy
BACKGROUND: The clinical impact of a chronic total occlusion (CTO) in patients with 3-vessel coronary artery disease undergoing fractional flow reserve–guided percutaneous coronary intervention (PCI) with current-generation drug-eluting stents or coronary artery bypass grafting (CABG) is unclear. METHODS: The FAME 3 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation 3) compared fractional flow reserve–guided PCI with CABG in patients with 3-vessel coronary artery disease. The primary end point was major adverse cardiac and cerebrovascular events, a composite of death, myocardial infarction, stroke, or repeat revascularization at 1 year. In this substudy, the 3-year outcomes were analyzed in patients with or without a CTO. RESULTS: Of the patients randomized to PCI or CABG in the FAME 3 trial, 305 (21%) had a CTO. In the PCI arm, revascularization of the CTO was attempted in 61% with a procedural success rate of 88%. The incidence of major adverse cardiac and cerebrovascular events at 3 years was not significantly different between those with or without a CTO in both the PCI (15.2% versus 20.1%; adjusted hazard ratio, 0.62 [95% CI, 0.38–1.03]; P =0.07) and the CABG (13.0% versus 12.9%; adjusted hazard ratio, 0.96 [95% CI, 0.55–1.66]; P =0.88) arms. In those without a CTO, PCI was associated with a significantly higher risk of major adverse cardiac and cerebrovascular events compared with CABG (adjusted hazard ratio, 1.61 [95% CI, 1.20–2.17]; P P =0.56; P interaction =0.31). CONCLUSIONS: The presence of a CTO did not significantly impact the treatment effect of PCI versus CABG at 3 years in patients with 3-vessel coronary artery disease. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02100722.
- 26 August 2024
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 17 (16) , 1861-1871
Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach
- 26 August 2024
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 17 (16) , 1861-1871
Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach
- 11 September 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (17) , 2112-2119
Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease
- 11 September 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (17) , 2112-2119
Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease
- 14 August 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (15) , 1937-1938
First Report of Visualization of Z-Shape Phenomenon by Optical Coherence Tomography
- 14 August 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (15) , 1937-1938
First Report of Visualization of Z-Shape Phenomenon by Optical Coherence Tomography
- Open Access
- 7 July 2023
- Published by Elsevier in JACC: Case Reports
- Vol. 20, 101950
Challenge in Diagnosis and Management of a Patient With Myocardial Bridge and Coronary Artery Spasm
- 7 July 2023
- Published by Elsevier in JACC: Case Reports
- Vol. 20, 101950
Open AccessChallenge in Diagnosis and Management of a Patient With Myocardial Bridge and Coronary Artery Spasm
- 9 December 2022
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 35 (1) , E46-E54
Complementary Utility of Intravascular Lithotripsy With Atherectomy for Severely Calcified Coronary Stenoses in Contemporary Practice
In this study, effectiveness and safety outcomes were compared between patients undergoing intravascular lithotripsy with and without atherectomy.
- 9 December 2022
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 35 (1) , E46-E54
Complementary Utility of Intravascular Lithotripsy With Atherectomy for Severely Calcified Coronary Stenoses in Contemporary Practice
In this study, effectiveness and safety outcomes were compared between patients undergoing intravascular lithotripsy with and without atherectomy.